Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 451

1.

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.

Rabe T, Saenger N, Ebert AD, Roemer T, Tinneberg HR, De Wilde RL, Wallwiener M.

Biomed Res Int. 2018 Jun 24;2018:1374821. doi: 10.1155/2018/1374821. eCollection 2018.

PMID:
30539001
2.

Therapy with Ulipristal Acetate in a Hypertensive Patient.

Alcalde Dominguez A, Rabasa Antonijuan J, Cusidó Gimferrer M, Ortuño MJ.

Case Rep Med. 2018 Nov 1;2018:1091520. doi: 10.1155/2018/1091520. eCollection 2018.

3.

1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids.

Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q.

Reprod Sci. 2018 Dec 4:1933719118812720. doi: 10.1177/1933719118812720. [Epub ahead of print]

PMID:
30514160
4.

Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center.

Gracia M, Nonell R, Ros C, Rius M, Quintas L, Martínez-Zamora MÁ, Carmona F.

Eur J Obstet Gynecol Reprod Biol. 2018 Nov 6;232:40-45. doi: 10.1016/j.ejogrb.2018.11.009. [Epub ahead of print]

PMID:
30468982
5.

Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program.

Donnez J, Arriagada P, Marciniak M, Larrey D.

Expert Opin Drug Saf. 2018 Nov 21:1-8. doi: 10.1080/14740338.2018.1550070. [Epub ahead of print]

PMID:
30460871
6.

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.

Möller C, Bone W, Cleve A, Klar U, Rotgeri A, Rottmann A, Schultze-Mosgau MH, Wagenfeld A, Schwede W.

ChemMedChem. 2018 Nov 6;13(21):2271-2280. doi: 10.1002/cmdc.201800487.

7.

Pericoital contraception.

Cahill EP, Blumenthal PD.

Curr Opin Obstet Gynecol. 2018 Dec;30(6):400-406. doi: 10.1097/GCO.0000000000000491.

PMID:
30399016
8.

[Emergency contraception: CNGOF Contraception Guidelines].

Hamdaoui N, Cardinale C, Agostini A.

Gynecol Obstet Fertil Senol. 2018 Oct 30. pii: S2468-7189(18)30261-7. doi: 10.1016/j.gofs.2018.10.006. [Epub ahead of print] French.

PMID:
30389544
9.

Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids.

Conway F, Morosetti G, Camilli S, Martire FG, Sorrenti G, Piccione E, Zupi E, Exacoustos C.

Gynecol Endocrinol. 2018 Nov 1:1-4. doi: 10.1080/09513590.2018.1505846. [Epub ahead of print]

PMID:
30382803
10.

Access to emergency contraception in Kansas City clinics.

French VA, Rangel AV, Mattingly TL.

Contraception. 2018 Dec;98(6):482-485. doi: 10.1016/j.contraception.2018.06.011. Epub 2018 Jul 3.

PMID:
30369407
11.

Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression.

Nasr M, Farghaly M, Elsaba T, El-Mokhtar M, Radwan R, Elsabahy M, Abdelkareem A, Fakhry H, Mousa N.

Int J Biochem Cell Biol. 2018 Dec;105:84-93. doi: 10.1016/j.biocel.2018.10.005. Epub 2018 Oct 22.

PMID:
30359767
12.

Choice of contraceptives.

[No authors listed]

Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. No abstract available.

PMID:
30335731
13.

Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.

Liu JH, Soper D, Lukes A, Gee P, Kimble T, Kroll R, Mallick M, Chan A, Gillard P, Harrington A, Sniukiene V, Shulman LP.

Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002942. [Epub ahead of print]

PMID:
30303900
14.

Ulipristal acetate (Esmya): restrictions on use.

[No authors listed]

Drug Ther Bull. 2018 Nov;56(11):127. doi: 10.1136/dtb.2018.11.000033. Epub 2018 Oct 8.

PMID:
30297449
15.

[Ulipristal acetate and SPRM: A new entity for the therapeutic strategy for symptomatic myomas].

Fernandez H.

Gynecol Obstet Fertil Senol. 2018 Nov;46(10-11):671-672. doi: 10.1016/j.gofs.2018.09.003. Epub 2018 Oct 4. French. No abstract available.

PMID:
30293948
16.

Development of a Novel Computerized Clinical Decision Support System to Improve Adolescent Sexual Health Care Provision.

Miller MK, Mollen C, Behr K, Dowd MD, Miller E, Satterwhite CL, Stancil S, Allen N, Michael J, Inboriboon PC, Park A, Goggin K.

Acad Emerg Med. 2018 Sep 21. doi: 10.1111/acem.13570. [Epub ahead of print]

PMID:
30240032
17.

A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.

Ng SSM, Jorge S, Malik M, Britten J, Su SC, Armstrong CR, Brennan JT, Chang S, Baig KM, Driggers PH, Segars JH.

J Clin Endocrinol Metab. 2018 Sep 14. doi: 10.1210/jc.2018-01216. [Epub ahead of print]

PMID:
30239831
18.

State of emergency contraception in the U.S., 2018.

Haeger KO, Lamme J, Cleland K.

Contracept Reprod Med. 2018 Sep 5;3:20. doi: 10.1186/s40834-018-0067-8. eCollection 2018. Review.

19.

Liver injury and ulipristal acetate: an overstated tragedy?

Donnez J.

Fertil Steril. 2018 Sep;110(4):593-595. doi: 10.1016/j.fertnstert.2018.06.044. No abstract available.

PMID:
30196943
20.

Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.

Zigler RE, Madden T, Ashby C, Wan L, McNicholas C.

Obstet Gynecol. 2018 Oct;132(4):888-894. doi: 10.1097/AOG.0000000000002810.

PMID:
30130351

Supplemental Content

Loading ...
Support Center